| RS2105817078 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS2105817176 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105820158 |
CERKL
|
Health Risk |
Pathogenic |
— |
| RS2105822776 |
SATB2
|
Health Risk |
Likely pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS2105822848 |
SATB2
|
Health Risk |
Pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS2105823042 |
NCKAP1
|
Health Risk |
Likely pathogenic |
— |
| RS2105823081 |
NCKAP1
|
Health Risk |
Likely pathogenic |
Global developmental delay, Global developmental delay |
| RS2105823583 |
SATB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS2105827235 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS2105827355 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105827770 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105827881 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS2105827941 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105828550 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS2105829160 |
SCN1A
|
Health Risk |
Pathogenic |
Seizure, Seizure |
| RS2105829215 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105832057 |
CERKL
|
Health Risk |
Pathogenic |
— |
| RS2105832223 |
CERKL
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 26, Retinitis pigmentosa 26 |
| RS2105832274 |
CERKL
|
Health Risk |
Likely pathogenic |
— |
| RS2105834651 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105835707 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105837590 |
SLC25A12
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 1 |
| RS2105840261 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS2105841790 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS2105841828 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105842394 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105843194 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105843552 |
SCN1A
|
Health Risk |
Pathogenic |
Seizure, Early-infantile DEE |
| RS2105844086 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS2105844138 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105844323 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105844439 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105846538 |
CERKL
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 26, Retinitis pigmentosa |
| RS2105846669 |
CERKL
|
Health Risk |
Pathogenic |
— |
| RS2105846718 |
CERKL
|
Health Risk |
Pathogenic |
— |
| RS2105846763 |
CERKL
|
Health Risk |
Pathogenic |
— |
| RS2105849998 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS2105850080 |
SATB2
|
Health Risk |
Likely pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS2105850165 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS2105850258 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS2105850381 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105851315 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105851392 |
CRYGD
|
Health Risk |
Pathogenic/Likely pathogenic |
Aculeiform cataract, Aculeiform cataract |
| RS2105851438 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105851829 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS2105851922 |
SCN1A
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS2105852267 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Seizure |
| RS2105857780 |
CRYGC
|
Health Risk |
Pathogenic |
— |
| RS2105857860 |
CRYGC
|
Health Risk |
Pathogenic |
— |
| RS2105857887 |
CRYGC
|
Health Risk |
Likely pathogenic |
Nuclear pulverulent cataract, Nuclear pulverulent cataract |
| RS2105857937 |
CRYGC
|
Health Risk |
Pathogenic |
Cataract 2, multiple types |
| RS2105858730 |
SLC25A12
|
Health Risk |
Likely pathogenic |
— |
| RS2105858978 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS2105859007 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS2105859077 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS2105859138 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS2105860766 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105861043 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105861331 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105861548 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Developmental and epileptic encephalopathy 6B |
| RS2105862149 |
SCN1A
|
Health Risk |
Likely pathogenic |
Autosomal dominant epilepsy, Autosomal dominant epilepsy |
| RS2105862170 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105862220 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS2105862310 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105862483 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105862581 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105862847 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105862926 |
SCN1A
|
Health Risk |
Pathogenic |
Migraine, familial hemiplegic |
| RS2105862987 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS2105865785 |
SATB2
|
Health Risk |
Pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS2105865877 |
SATB2
|
Health Risk |
Pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS2105865970 |
SATB2
|
Health Risk |
Pathogenic |
— |
| RS2105866649 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105866757 |
SCN1A
|
Health Risk |
Pathogenic |
Seizure, Seizure |
| RS2105867004 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS2105867367 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105867534 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS2105867988 |
SATB2
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2105867993 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105868016 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105868028 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS2105868295 |
SCN1A
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS2105868306 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105868996 |
NCKAP1
|
Health Risk |
Likely pathogenic |
NCKAP1-associated Neurodevelopmental disorder, NCKAP1-associated Neurodevelopmental disorder |
| RS2105874070 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS2105874088 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105874284 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105874408 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105874493 |
SCN1A
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS2105876276 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS2105885940 |
SLC25A12
|
Health Risk |
Pathogenic |
— |
| RS2105888351 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS2105888359 |
ABCB11
|
Health Risk |
Pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS2105888495 |
SCN1A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2105888708 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105888823 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS2105888862 |
ABCB11
|
Health Risk |
Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS2105888928 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105889320 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105889854 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |